Unresectable Renal Cell Carcinoma

12 clinical trials · Condition

Record	Firm	Date
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546)	City of Hope Medical Center	2021-11-01
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (NCT04603365)	Jonsson Comprehensive Cancer Center	2021-10-18
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer (NCT04337970)	Memorial Sloan Kettering Cancer Center	2020-04-06
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer (NCT03829111)	City of Hope Medical Center	2019-05-14
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) (NCT03595124)	National Cancer Institute (NCI)	2019-01-08
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT03334409)	Academic and Community Cancer Research United	2018-02-16
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed (NCT02761057)	National Cancer Institute (NCI)	2016-07-25
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies (NCT02419495)	M.D. Anderson Cancer Center	2015-06-26

Every clearance here is in the API, with alerts when new ones post.